Relationship Between Muscle Mass and Insulin Resistance in Cirrhotic Patients with Hepatitis B

Relationship Between Muscle Mass and Insulin Resistance in Cirrhotic Patients with Hepatitis B

INTRODUCTION[|]Hepatitis B virus (HBV) affects over 400 million people in the world and is a major threat despite all measures taken for its prevention. It is one of the most important causes of liver cirrhosis. Liver cirrhosis causes malnutrition as a result of decreased oral intake, both because o...

Full description

Bibliographic Details
Main Authors:	Eyüp Sami Akbaş, Betül Ayaz, Beyza Selin Haksever, Sema Basat
Format:	Article
Language:	English
Published:	KARE Publishing 2019-07-01
Series:	Southern Clinics of Istanbul Eurasia
Subjects:	cirrhosis hepatitis b insulin resistance; muscle mass.
Online Access:	https://jag.journalagent.com/z4/download_fulltext.asp?pdir=scie&un=SCIE-03164

Similar Items

Previous hepatitis E virus infection, cirrhosis and insulin resistance in patients with chronic hepatitis C
by: Guilherme Bricks, et al.
Published: (2019-05-01)

Loss of skeletal muscle mass affects the incidence of minimal hepatic encephalopathy: a case control study
by: Masakuni Tateyama, et al.
Published: (2020-11-01)

Dyspepsia in Cirrhotic Hepatitis C Patients
by: Maryam Jalil
Published: (2017-12-01)

Rifaximin ameliorates intestinal inflammation in cirrhotic patients with hepatic encephalopathy
by: Yasuyuki Tamai, et al.
Published: (2021-07-01)

Efficacy and safety of entecavir and/or tenofovir in hepatitis B compensated and decompensated cirrhotic patients in clinical practice
by: Mireia Miquel, et al.
Published: (2013-03-01)

Correlation of serum betatrophin levels with disease severity and the emergence of insulin resistance in cirrhotic patients
by: Mohamed Magdy Salama, et al.
Published: (2020-08-01)

Individual and combined effects of octreotide and terlipressin on hepatic venous pressure gradient in cirrhotic patients
by: XIA Yulian
Published: (2015-02-01)

An unfortunate failure: multifocal hepatocellular carcinoma in a non-cirrhotic patient with chronic hepatitis C treated with ledipasvir/sofosbuvir
by: Megan Sue Soliman, et al.
Published: (2018-05-01)

Efficacy of oral L-ornithine L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy
by: Claudia Isabel Blanco Vela, et al.
Published: (2011-01-01)

Muscle depletion in cirrhotic patients assessed using computed tomography: a cross-sectional study
by: Elisa Sfoggia Romagna, et al.

Efficacy of entecavir combined with alprostadil in treatment of hepatitis B-related cirrhotic ascites
by: LI Huili, et al.
Published: (2016-02-01)

Gut microbiome in cirrhotic hepatitis C virus patients with and without hepatocellular carcinoma
by: Khaled Mohieldeen, et al.
Published: (2021-09-01)

The Impact of Previous Acute Decompensation on the Long-Term Prognosis of Alcoholic Hepatitis in Cirrhotic Patients
by: Eileen L. Yoon, et al.
Published: (2019-10-01)

Chronic hepatitis B exhibited higher rate of hepatocellular carcinoma occurrence than hepatitis C in cirrhotic patients after effective antiviral treatment
by: Ming-Tsung Lin, et al.
Published: (2021-01-01)

Low-level viremia and cirrhotic complications in patients with chronic hepatitis B according to adherence to entecavir
by: Seung Bum Lee, et al.
Published: (2020-07-01)

TRPM5 rs886277 Polymorphism Predicts Hepatic Fibrosis Progression in Non-Cirrhotic HCV-Infected Patients
by: Salvador Resino, et al.
Published: (2021-01-01)

ASCITES IN THE CIRRHOTIC PATIENT: HOW TO APPROACH IT? (IN SPANISH)
by: Yepes-Barreto Ismael, et al.
Published: (2014-06-01)

Performance of albumin-bilirubin score in prediction of hepatic encephalopathy in cirrhotic patients with acute variceal bleeding
by: Rehab Elsayed Elsafty, et al.
Published: (2021-03-01)

Severe back pain a cirrhotic patient : a diagnostic challenge
by: Ioana Stănescu, et al.
Published: (2018-05-01)

Movement Disorders in Non-Wilsonian Cirrhotic Patients: A Report of the Prevalence and Risk Factors from a Study Done in a Medical School in an Agricultural-Based Community
by: Kulthida Methawasin, et al.
Published: (2016-01-01)

Grading antiviral therapy in HCV-infected cirrhotic patients
by: ZHANG Ying
Published: (2013-02-01)

Sofosbuvir add-on to ribavirin for chronic hepatitis E in a cirrhotic liver transplant recipient: a case report
by: Montserrat Fraga, et al.
Published: (2019-05-01)

Evaluation of hepatitis A, B, and C serology in patients with cirrhosis and intensive alcohol consumption
by: Sezgin Vatansever, et al.
Published: (2018-06-01)

Liver stiffness measurement in cirrhotic patient — Implications of disease activity and treatment efficacy
by: Huang-Wei Xu, et al.
Published: (2012-12-01)

Antiviral therapy of HCV in the cirrhotic and transplant candidate
Published: (2006-04-01)

Hepatitis C Direct Acting Antivirals and Ribavirin Modify Lipid but not Glucose Parameters
by: Mary-Anne Doyle, et al.
Published: (2019-03-01)

Efficacy of oral L-ornithine-L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy. Results of a randomized, lactulose-controlled study
by: Jorge Luis Poo, et al.
Published: (2006-10-01)

Evaluation of the Sabadell noninvasive hepatitis C-related cirrhosis early detection index and right lobe diameter to albumin ratio in the prediction of presence of varices in Egyptian cirrhotic patients
by: Ghada M Kamal, et al.
Published: (2019-01-01)

Assessment of Serum Retinol Binding Protein 4 in Patients with Hepatocellular Carcinoma
by: Yehia Mohamed El Shazly, et al.
Published: (2018-10-01)

Exercising for Insulin Sensitivity – Is There a Mechanistic Relationship With Quantitative Changes in Skeletal Muscle Mass?
by: Jasmine Paquin, et al.
Published: (2021-05-01)

Polymicrobial multiple intraabdominal infections, a rare complication of colonoscopy in a cirrhotic patient
by: Syed Amer, et al.
Published: (2014-02-01)

PREVALENCE OF BACTERIAL RESISTANCE IN HOSPITALIZED CIRRHOTIC PATIENTS IN SOUTHERN BRAZIL: A NEW CHALLENGE
by: Ane Micheli COSTABEBER, et al.
Published: (2016-01-01)

Occult hepatitis B among Iranian hepatitis C patients
by: Ahmad shavakhi, et al.
Published: (2009-02-01)

Antiviral therapy in HCV-infected decompensated cirrhotics
by: Danish Fazal, et al.
Published: (2010-01-01)

Expression of Cytoskeletal Proteins in Hepatic Stellatecells Isolated from Normal and Cirrhotic Rat Liver
by: Alena Jiroutová, et al.
Published: (2005-01-01)

PARTIAL PORTOSYSTEMIC SHUNTING BY CARBON-COATED ePTFE GRAFTS FOR PORTAL HYPERTENSION IN CIRRHOTIC PATIENTS
by: I. A. Porshennikov, et al.
Published: (2010-06-01)

A Hepatitis C Virus-Associated Decompensated Cirrhotic Patient Who Showed the Disappearance of Hepatic Encephalopathy, Ascites, and Pleural Effusion by Antiviral Therapy with Sofosbuvir/Velpatasvir
by: Kazuo Tarao, et al.
Published: (2021-04-01)

Effectiveness and Safety of Pangenotypic Regimens in the Most Difficult to Treat Population of Genotype 3 HCV Infected Cirrhotics
by: Dorota Zarębska-Michaluk, et al.
Published: (2021-07-01)

Differential distribution of age and HBV serological markers in liver cirrhosis and non-cirrhotic patients with primary liver cancer
by: XU Xiuhua
Published: (2013-03-01)

Insulin growth factor-1 and insulin growth factor binding protein-3 in Egyptian patients with chronic hepatitis C
by: Hala Mohamed Raslan, et al.
Published: (2007-03-01)

Cannot write session to /tmp/vufind_sessions/sess_2mcdr7nvljrh9g1fqq9ii6ahou